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Abstract
In the past decade, there has been an increase in genomic research and biobanking activities in Africa. Research
initiatives such as the Human Heredity and Health in Africa (H3Africa) Consortium are contributing to the
development of scientific capacity and infrastructure to support these studies on the continent. Despite this
growth, genomic research and biobanking have raised important ethical challenges for key research stakeholders,
including members of research ethics committees. One of these is the limited ethical and regulatory frameworks to
guide the review and conduct of genomic studies, particularly in Africa. This paper is a reflection on a series of
consultative activities with research ethics committees in Africa which informed the development of an ethics and
governance framework for best practices in genomic research and biobanking in Africa. The paper highlights the
engagement process and the lessoned learned.
Background
The Human Heredity and Health in Africa (H3Africa)
Initiative [1] is a pan-African research initiative which
aims to contribute to the development of scientific cap-
acity and infrastructure to support the conduct of gen-
omic research and biobanking on the African continent.
Some of the key features of this initiative include its col-
laborative nature, bringing together interdisciplinary
teams of researchers, institutions and communities from
across the continent, the collection of human biological
specimens including blood for DNA extraction, and the
broad sharing of samples and data for secondary re-
search use. Genomic research and biobanking raise im-
portant ethical questions such as those related to: what
should count as valid consent for data and sample
sharing; how to maintain participants’ privacy; how to
ensure that the voice of the population in which the
study is being done is heard through community engage-
ment; ownership of samples and data; and benefit shar-
ing [2–5]. Although many of these issues are not unique
to the African context, a key ethical challenge in the
conduct of genomic research and biobanking in Africa is
the limited ethics and regulatory guidance to inform the
design, review and conduct of these studies, on the con-
tinent and internationally. In the first round of funding
for H3Africa (2013–2017), it emerged that many African
countries lacked the appropriate frameworks to support
these studies and many research ethics committees
(RECs) were not familiar with reviewing proposals for
genomic research and biobanking [6–8]. For example,
the concept of broad consent, which allowed potential re-
search participants to give consent for the broad use of
their samples and data including secondary use and was
the proposed model for H3Africa projects, became a sub-
ject of intense debate among key research stakeholders
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including RECs. Questions were raised about its appropri-
ateness in the African research context since RECs will
not be able to track the status of stored samples when they
leave the Continent. Also, there were concerns that given
the level of literacy in Africa, participants would not
understand the rationale for future use of samples and
data. These concerns were similar to those reported else-
where [7, 9].
The H3Africa Consortium adopted several approaches
to address these ethical challenges through the work of
the H3Africa Ethics and Regulatory Issues Working
Group and the H3Africa Community Engagement
Working Group (CEWG), of which the authors of this
manuscript are a part. These Working Groups are re-
sponsible for developing appropriate ethics and commu-
nity engagement policies and guidelines [10, 11] for
H3Africa projects as well as supporting empirical studies
addressing the ethical, legal, social and cultural implica-
tions of genomic research and biobanking in Africa.
These two groups have since been joined and in the re-
mainder of this paper, we will refer to these groups as
‘the Working Group’.
Given the limited ethics guidance available to support
these studies, particularly on the African continent and
repeated calls for guidance from ethics committees and
other stakeholders, the Working Group deemed it neces-
sary to develop a framework to address the growing con-
cerns about the conduct of genomic studies and
biobanking in Africa [6]. The purpose of the ethics
framework was to provide key elements of best practice
to guide the design, review and conduct of genomic re-
search and biobanking in Africa and to serve as a guide
for the development of specific institutional and national
guidelines and policies for genomic research and bio-
banking across the continent [12]. But when considering
the development of such a framework, what became ob-
vious is that central to its development should be the
voices and perspectives of different stakeholders that
would work with and apply it. We thought this was im-
portant not only to increase the relevance and legitimacy
of the framework, but also because broad engagement is
a key element of ensuring that research fulfils the goals
of justice [13]. Thus, in the process of developing this
document we engaged members of RECs, as stewards in
promoting ethical research, researchers and other key
African stakeholders including national and regional
regulatory authorities.
In this paper we describe this engagement process
with REC members and the other key stakeholders as
well as lessons learned in the development of an ethics
and governance framework for best practice in genomic
research and biobanking in Africa. A separately pub-
lished manuscript discusses the main content of the
framework and is open access [14].
Discussion
Our engagement approach: ethics consultation and
deliberative workshops
Community and stakeholder engagement is increasingly
gaining prominence as an important process that can
support the successful implementation of genomic re-
search and biobanking, particularly in facilitating the
sharing of information with target communities and
stakeholders and addressing the ethical issues that arise
in practice [15–18]. One key approach to community
and stakeholder engagement is consultation, which pro-
vides two-way communication and a platform for stake-
holders to deliberate on key issues of common interest.
While project-specific community engagement activities
with members of the lay public were being conducted
across the H3Africa Consortium [19, 20], the need to
engage with RECs became increasingly obvious for two
reasons. First, genomic research is collaborative, and
RECs have a gatekeeper role to ensure the safety of re-
search participants. With this, they have the power to
delay or otherwise obstruct research or to approve and
facilitate research. It is now well-established that many
of the ethics committees on the continent are deeply un-
comfortable with the export, storage and re-use of sam-
ples and data, not in the least out of fear that these
practices would fuel exploitation of African researchers
and populations [21]. For H3Africa projects seeking eth-
ics approval, these fears translated into long delays in
obtaining ethics approval. For the Working Group, one
way of addressing these fears was to engage with mem-
bers of RECs to understand better the root of these fears
and to work with them in finding constructive solutions.
Second, RECs are the most visible entity protecting the
values of the institutions and communities involved in
research. Although there are obvious limitations to their
ability to act in this capacity, the Working Group felt
that it was crucially important that the views of these
committees were heard and taken seriously in the design
of guidance developed by the H3Africa Consortium.
The Consortium’s approach to engaging with the key
stakeholders was to organise a series of consultation work-
shops to identify the key practical and ethical challenges
from the perspective of those involved in reviewing and
regulating these studies and to solicit their views on how
these challenges can be addressed. The format for these
workshops included presentations, plenary and group dis-
cussions. To support a more deliberative process, the work-
shops were structured in a way that allowed more time for
both open and group discussions. The format also involved
presenting various views on the subject matter and eliciting
the views of workshop participants on what would count as
best practices. In what follows, we describe the components
of these consultation workshops, lessons learned and how
they contributed to the development of the ethics and
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governance framework for best practice in genomic re-
search and biobanking in Africa.
1st consultation meeting: Cape Town South Africa, June
2014
The first consultation workshop was held in Cape Town,
South Africa in June 2014. Sixty members from 40 RECs
in 18 African countries, principal investigators and fun-
ders of the H3Africa Consortium attended the work-
shop. REC members were purposively selected from
RECs that were involved in the review of H3Africa re-
search protocols. The response to the workshop invita-
tions were generally positive. Only a few invitees
declined to attend the workshops due to conflicts with
the proposed dates.
The focus of this workshop was to provide a platform for
members to share their experiences in the review of H3Af-
rica protocols, including the concerns they have with some
of the key features of the projects such as sample and data
sharing and the use of broad consent. Two brief presenta-
tions were made at the beginning of the workshop. The first
focused on the scientific rationale for conducting genomic
research in Africa, an overview of the H3Africa projects,
the governance structures that have been established by the
Consortium on consent, community engagement and data
sharing. The second presentation focused on the key ethical
issues highlighted in the literature and the various perspec-
tives on consent for genomic research globally. It also pro-
vided an opportunity for participants to learn from research
practices outside the H3Africa Consortium and to deliber-
ate on the best way forward in addressing the key ethical is-
sues arising in practice.
The key issues that dominated the discussions were the
concept of broad consent [22], community engagement
and the role of local RECs in decisions on secondary use
of samples. It became apparent that the lack of clarity on
the definition of broad consent and how to differentiate it
from blanket consent, which has no restriction on future
secondary use, was creating anxieties among the REC
members. The workshop provided an opportunity to ex-
plore the nature of these concerns, get a sense of ethics
committee’s general perceptions on genomic research and
biobanking and identify potential pitfalls that would need
to specifically be addressed in H3Africa guidelines and
policies. Importantly, the meeting also offered an oppor-
tunity for the H3Africa Consortium to receive input on its
draft data and sample sharing policy.
The outcome of this workshop informed the revision of
the H3Africa Informed Consent Guidelines [10], which
clarified the concept of broad consent. Two empirical eth-
ics projects focusing on community engagement [23] and
an analysis of the consent forms used across the H3Africa
Consortium [24] were also conducted. Furthermore, the
meeting led to a revision of the draft H3Africa sample and
data sharing policy, particularly with regards to including
a process for ensuring regular feedback to the ethics com-
mittees that first approved sample collection about data
and sample use requests.
2nd consultation meeting: Livingstone, Zambia, may 2015
Following the success of the first consultation workshop
and the need for further discussions on what would con-
stitute best practices for conducting genomic research
and biobanking in Africa, a second workshop was held
in Livingstone, Zambia in May 2015 [24]. The nature of
discussions about the consent processes for African gen-
omic research at the first meeting led us to focus this
second meeting more explicitly on broad consent. Spe-
cifically, this meeting sought to explore perspectives on
the use of broad consent but also the nature of the gov-
ernance framework that should accompany it. To ensure
some continuity of the engagement process, participants
of the first consultation meeting were invited to this
meeting. The need to start including regulatory bodies
was seen as necessary to ensuring that the future gov-
ernance framework would inform the development of
national frameworks across Africa. This was partly a rec-
ommendation made by participants in the first Consult-
ation meeting.
At this second meeting, there were clear indications
that the perspectives of members of RECs on broad con-
sent as the best option for genomic research and bio-
banking had evolved since the first meeting, with greater
apparent support for this type of consent [24]. The dis-
cussions had moved from ‘what are the ethical issues we
are concerned about’ to ‘how should we address the eth-
ical issues arising in practice’ and ‘what governance
mechanisms should support the use of broad consent’.
The meeting called for clear guidelines and regulations
across the African continent. The meeting also called for
harmonisation of approaches and guidelines across the
continent. The reason for this is that much of the re-
search conducted in Africa happens in collaboration be-
tween African partners or with non-African partners. In
those cases, significant differences in approaches be-
tween partners has been known to cause delays and ob-
struct collaboration. There is also a concern that if only
some countries adopt strict regulations (for instance,
stipulating that all collaborative research requires a part-
ner for the country) that international partners would
avoid those countries and rather work with researchers
in countries where regulation is less strict. The discus-
sions at this workshop informed a project by the Working
Group to review existing guidelines and regulations on gen-
omic research and biobanking across Africa [6]. Overall,
the meeting concluded with an affirmation of our view that
the absence of guidance documents that are relevant to the
African context to help ethics committees make sense of
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genomic research and biobanking research proposals,
formed a real obstruction to committees’ ability to ad-
equately review such proposals. The consultation process
provided a great opportunity to clarify some of the dis-
agreements on the definitions of key terms such as broad
consent for data sharing, which had generated considerable
debate. The issues raised by workshop participants formed
the basis of the key principles and elements outlined in the
framework document.
Developing the framework
Taking the call for guidance for African genomic and
biobanking research seriously, we agreed that whilst it
was important to support such a process, we equally did
not feel that the expertise of the relatively small number
of active members of the Working Group had sufficient
experience to develop such a document alone. For this
reason, we decided to build on the relations developed
during the H3Africa consultation meetings and involve
key ethics committee members in the drafting process.
After preparing an initial draft in the group, we sourced
external funding that allowed us to organise a two-day
workshop in March 2016. This meeting involved members
of ethics committees in three countries (Botswana, Ethiopia
and Uganda), representatives of the two funding bodies
(NIH and the Wellcome Trust), a member of the South
African Academy of Science, an African philosopher, and
selected members of the Working Group. During this
meeting, we fostered discussion on all components of the
framework, including critical questions of definition, scope
and philosophical orientation.
The team deliberated on the foundational philosophy
of the document, the principles that would serve as the
basis of the governance mechanism that was idealised
and the elements that explained the operationalization
of such principles in practice. To avoid reinventing the
wheel, the team drew on existing ethics frameworks such
as the Framework for the Responsible Sharing of Gen-
omic and Health-Related Data developed by the Global
Alliance for Genomics and Health (GA4GH) [25] as well
as the OECD Guidelines on Human Biobanks and Gen-
etic Research Databases [26], the Wellcome Trust
Framework on the Feedback of Health-Related Findings
in Research [27], the European Commissions’ reports on
Global Governance of Science [28], the Ethical and
Regulatory Challenges to Science and Research Policy at
the Global Level [29] and country- specific ethics guide-
lines from 23 African countries, some of which were
specific to genomic research and biobanking [6].
We used the resulting draft to engage broadly with stake-
holders involved in genomic research and biobanking inter-
nationally and in Africa. We engaged quite extensively, for
instance with the Bridging Biobanking and Biomedical Re-
search across Europe and Africa (B3Africa) [30] and TRUST
projects funded by the European Union, which focus on bio-
banking in Africa and on international research ethics re-
spectively. We also received input from the P3G
Consortium [31], which develops policy tools and provides
ethics support for public and private health research initia-
tives. Inputs were integrated into the draft Framework.
3rd consultation meeting: Dakar, Senegal, may 2016:
consensus building on ethics framework
The 3rd Consultation meeting was convened in Dakar,
Senegal in May 2016 to deliberate on the draft ‘Ethics
and Governance Framework for Best Practice in Gen-
omic Research and Biobanking in Africa’ as part of the
process of finalising the revised version of the Frame-
work and to identify the mechanism to support its im-
plementation across the continent.
In all, 40 participants from Ministries of Health, National
Ethics Councils, REC members, research institutes, the Af-
rican Academy of Sciences, the National Institutes of
Health and the Wellcome Trust participated in this work-
shop. Participants discussed each of the elements in the
draft Ethics and Governance Framework in groups and
provided feedback on what needed to be changed or im-
proved and what was missing. One of the key areas of dis-
cussion related to the African philosophical orientation that
should underpin the key elements proposed in the frame-
work. The draft document had relied on the Ubuntu phil-
osophy [32], which highlights the interrelatedness and
interconnectedness of people, as the basis for what should
count as good ethical practice in Africa, particularly on the
need to share samples and data. However, some partici-
pants at the workshop felt that Ubuntu is limited to South
African philosophy and that it has strong political connota-
tion in that country. They suggested that it might be neces-
sary to identify a common African philosophical thought
that cultures across the continent could identify with. Based
on these discussions, Ubuntu was removed from the final
document and replaced with text highlighting communal
and solidarity-based worldviews, which are common across
many cultures in Africa.
At the end of this third consultation meeting, a commu-
niqué was developed based on the key recommendations
from the stakeholders’ discussions. The document called
for greater involvement and engagement with regional
governance organisations such as the African Union and
the African Academy of Science to push for African gov-
ernments to support funding on genomic research and
biobanking and to facilitate the development of relevant
national and regional guidelines and policies to support
genomic research and biobanking across the continent.
Other matters arising and next steps
The final Ethics and Governance framework document
has been shared with all the participants who attended
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the three workshops as well as the wider research com-
munity online. [12] As part of its dissemination efforts,
members of the Working Group have presented the
framework at several national and international confer-
ences, including the 10th International Association of
Bioethics Congress held in Edinburgh in June 2016. An
implementation guide is being developed to support the
uptake of this framework across the continent.
Lessons learned
Our experience has taught us several valuable lessons
that can guide future engagement activities with RECs,
regulators and policy makers on the African continent in
line with our approach. First of these is the importance
of funding and support in organising these events. Fund-
ing for these workshops was not available in any one
H3Africa project. Rather, the funding bodies backing
H3Africa (the NIH and the Wellcome Trust) supported
these initiatives with funding they sourced purposively
for these meetings. We would recommend that this type
of funding support should be a feature of research initia-
tives and should consider engagement with RECs as an
important step to addressing the key ethical challenges
that would arise in practice. Second, the Working Group
received support from many different stakeholders re-
sponsible for its success – researchers, the H3Africa
steering committee and external advisory board, and the
H3Africa funders. Without such support, organising
these meetings and ensuring that lessons learnt were
translated into the guidance developed, would have been
difficult if not impossible.
Another lesson is the importance of having ‘champions’
that believe in the value of engagement and, equally im-
portant, that believe in the importance of medical research
to help address illnesses affecting African populations.
Over the course of our work, we identified two kinds of
champions – those involved in H3Africa research and the
Working Group and members of research ethics commit-
tees outside it. In terms of the first, there was a small but
significant group of enthusiastic individuals, each with
their own day-job, who believed in the value of engage-
ment and who were willing to put in the hours to make it
happen. But more importantly, through the course of our
Consultation Meetings, we identified members of ethics
committees that were experienced with genomic research
and biobanking who spoke out and added significant value
to the meeting deliberations and who were keen to ac-
tively participate in the drafting of the Framework for in-
stance. Importantly, they were responsive to email and
willing to travel. These ‘champions’ became our primary
source of engagement with the community of ethics com-
mittees that we were seeking to engage. Without their
perspectives, the development of the Framework would
not have been nearly as successful.
Early engagement with policy makers and regulatory
bodies is also very important to ensure mutual under-
standing of the key concerns these stakeholders might
have and to ensure that policies are developed appropri-
ately to address these issues.
As these workshops were more consultative, the issues
raised by the participants informed the key principles
and elements outlined in the framework document. We
believe that these processes served several purposes; by
strengthening understanding of genomic research and
the key ethical considerations that should guide the de-
sign, review and implementation of these projects. The
workshops also demonstrated to the RECs that the
H3Africa consortium was not only focusing on the sci-
entific aspects of the project but also concerned about
promoting the ethical conduct of these projects by iden-
tifying and addressing them as they arise through appro-
priate governance structures.
Not all RECs in Africa were involved in these consult-
ation workshops and while concerns about the appropri-
ateness of broad consent in Africa evolved overtime, we
acknowledge that the debates on broad consent are not
over. There is therefore the need to sustain these con-
sultation workshops with RECs and regulatory bodies
and undertake facilitation in a way that allows diverse
and dissenting voices to be captured. These processes
could contribute to building trust between these various
research actors and facilitate the ethical conduct of gen-
omic research in Africa. It will also be important to con-
duct further empirical studies to continue to build the
evidence-base to support consent models in Africa.
The framework has received some publicity in a Nature
editorial [33], and in the Journal of America Medical
Association (JAMA) [34] amongst others. More anec-
dotally, in empirical research we conducted with REC
members in Ghana, Uganda [35] and Zambia [36] we
heard the H3Africa engagement process and the frame-
work referred to as a source of knowledge and as instru-
mental in the development of appropriate review
processes. Going forward, the Working Group plans to
monitor the impact of this framework through a continu-
ous process of engagement with members of ethics com-
mittees and national policy makers.
Conclusion
This paper has demonstrated a bottom-up approach to
developing an ethics and governance framework and the
role of stakeholder engagement in facilitating the devel-
opment process. Using a consultation approach to en-
gage REC members and regulatory authorities ensured
that the concerns of these key stakeholders were consid-
ered and used to inform the development and review of
H3Africa policy documents and guidelines. It has also
highlighted the need to create more opportunities for
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communication between researchers, RECs and regula-
tory bodies across the continent to facilitate the ethical
conduct of research. Going forward, the H3Africa Con-
sortium is keen to support the implementation phase of
the framework. Given the limited opportunities for RECs
to meet and network on the continent, these consult-
ation workshops have set the stage to sustain face to face
interactions. We call on the African Union and the African
Academy of Sciences to support an initiative that will sup-
port a strong network of RECs across Africa. This should
inform fostering a harmonised approach to the regulation
of genomic research and biobanking on the continent and
the development of ethics review equivalency agreements
between committees.
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